EPA-enriched oral nutritional support in patients with lung cancer: Effects on nutritional status and quality of life

Nutritional Therapy and Metabolism

Volumn 25, Issue 1, 2007, Pages 25-30

  Guarcello, Marianna ^a   Riso, S ^a   Buosi, R ^a   D'Andrea, F ^a  

^a MAGGIORE DELLA CARITÀ HOSPITAL   (Italy)

Author keywords

EPA; Lung cancer; Nutritional status; Nutritional support; Quality of life

Indexed keywords

EID: 46849116060     PISSN: 18286232     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Van Bokhorst-van der Schueren MA, van Leeuwen PA, Sauerwein HP, et al. Assessment of malnutrition parameters in head and neck cancer and their relation to postoperative complications. Head Neck 1997; 19: 419-25.
2. Wigmore SJ, Fearon KCH, Maingay JP, Lai PB, Ross JA. Interleukin-8 can mediate acute-phase protein production by isolated human hepatocytes. Am J Physiol 1997; 273: E720-6.
3. Strassmann G, Fong M, Kenney JS, Jacob CO. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 1992; 89: 1681-4.
4. Cariuk P, Lorite MJ, Todorov PT, Field WN, Wigmore SJ, Tisdale MJ. Induction of cachexia in mice by a product isolated from the urine of cachectic cancer patients. Br J Can 1997; 76: 606-13.
5. McDevitt TM, Todorov PT, Beck SA, Khan SH, Tisdale MJ. Purification and characterization of a lipid-mobilizing factor associated with cachexia-inducing tumors in mice and humans. Cancer Res 1995; 55: 1458-63.
6. Meydani S. Effects of (n-3) polyunsatured fatty acids on cytokine production and their biologic function. Nutrition 1996; 12: S8-14.
7. Wigmore SJ, Fearon KC, Maingay JP, Ross JA. Downregulation of the acute-phase response in patients with pancreatic cancer cachexia receiving oral eicosapentaenoic acid is mediated via suppression of interleukin-6. Clin Sci (Lond) 1997; 92: 215-21.
8. Wigmore SJ, Barber MD, Ross JA, Tisdale MJ, Fearon KC. Effect of oral eicosapentaenoic acid on weight loss in patients with pancreatic cancer. Nutr Cancer 2000; 36: 177-84.
9. Wigmore SJ, Ross JA, Falconer JS, et al. The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition 1996; 96: 27-30.
10. Barber MD, Ross JA, Voss AC, Tisdale MJ, Fearon KC. The effect of an oral nutritional supplement enriched with fish oil on weight-loss in patients with pancreatic cancer. Br J Cancer 1999; 81: 80-6.
11. Barber MD, Ross JA, Preston T, Shenkin A, Fearon KC. Fish oil-enriched nutritional supplement attenuates progression of the acute-phase response in weight-losing patients with advanced pancreatic cancer. J Nutr 1999; 129: 1120-5.
12. Fearon K, Von Meyenfeldt M, Moses A, et al, on behalf of the Cancer Cachexia Study Group. An energy and protein dense, high n-3 fatty acid oral supplement promotes weight gain in cancer cachexia. Eur J Cancer 2001; 37: S27-8.
13. Fearon KCH, von Meyenfeldt MF, Moses AGW, et al. Effect of a protein and energy dense n-3 fatty acid enriched oral supplement on loss of weight and lean tissue in cancer cachexia: a randomised double blind trial. Gut 2003; 52: 1479-86.
14. DeWys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patiens. Am J Med 1980; 69: 491-7.
15. Ovesen L, Allingstrup L, Hannibal J, Mortesen EL, Hansen OP. Effect of dietary counselling on food intake, body weight, response rate, survival, and quality of life in cancer patients undergoing chemotherapy: a prospective, randomized study. J Clin Oncol 1993; 11: 2043-9.
16. Evans WK, Nixon D, Daly JM, et al. A randomized study of oral nutritional support versus ad lib nutritional intake during chemotherapy for advanced colorectal and non-small cell lung cancer. J Clin Oncol 1987; 5: 113-24.
17. Tabelle di composizione degli alimenti. Istituto Nazionale di Ricerca per gli Alimenti e la Nutrizione (INRAN), 2000.
18. Simons JPFA, Aaronson NK, Vansteenkiste JF, et al. Effects of medroxyprogesterone acetate on appetite, weight and quality of life in advanced-stage non-hormonesensitive cancer: a placebo-controlled multicenter study. J Clin Oncol 1996; 14: 1077-84.
19. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality of life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993; 85: 365-76.
20. Elia M, Van Bokhorst-de van der Schueren MA, Garvey J, et al. Enteral (oral or tube administration) nutritional support and eicosapentaenoic acid in patients with cancer: a systematic review. Int J Oncol 2006; 28: 5-23.
21. Fearon KC, Barber MD, Moses AG, et al. Double-blind, placebo-controlled, randomized study of eicosapentaenoic acid diester in patients with cancer cachexia. J Clin Oncol 2006; 24: 3401-7.